WO2017065495A3 - Composition for treatment of inflammatory bowel disease and atopic dermatitis - Google Patents

Composition for treatment of inflammatory bowel disease and atopic dermatitis Download PDF

Info

Publication number
WO2017065495A3
WO2017065495A3 PCT/KR2016/011434 KR2016011434W WO2017065495A3 WO 2017065495 A3 WO2017065495 A3 WO 2017065495A3 KR 2016011434 W KR2016011434 W KR 2016011434W WO 2017065495 A3 WO2017065495 A3 WO 2017065495A3
Authority
WO
WIPO (PCT)
Prior art keywords
treatment
inflammatory bowel
bowel disease
atopic dermatitis
composition
Prior art date
Application number
PCT/KR2016/011434
Other languages
French (fr)
Korean (ko)
Other versions
WO2017065495A2 (en
Inventor
강인철
Original Assignee
주식회사 이노파마스크린
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020160131313A external-priority patent/KR101949451B1/en
Application filed by 주식회사 이노파마스크린 filed Critical 주식회사 이노파마스크린
Priority to EP16855712.2A priority Critical patent/EP3363783B1/en
Priority to JP2018519833A priority patent/JP6885607B2/en
Priority to US15/768,374 priority patent/US10278931B2/en
Priority to CN201680059836.6A priority patent/CN108137490B/en
Publication of WO2017065495A2 publication Critical patent/WO2017065495A2/en
Publication of WO2017065495A3 publication Critical patent/WO2017065495A3/en
Priority to HK18113385.6A priority patent/HK1254242A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/43—Guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/04—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C233/06—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/18—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/24—Y being a hetero atom
    • C07C279/26—X and Y being nitrogen atoms, i.e. biguanides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention relates to a compound for inhibiting the secretion of thymic stromal lymphopoietin (TSLP) from mast cells, and a use thereof. It has been confirmed that the compound of the present invention significantly inhibits the secretion of TSLP from mast cells, and thus the compound can be used as a candidate material for the treatment and prevention of atopic dermatitis, allergic dermatitis and/or inflammatory bowel disease.
PCT/KR2016/011434 2015-10-13 2016-10-12 Composition for treatment of inflammatory bowel disease and atopic dermatitis WO2017065495A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
EP16855712.2A EP3363783B1 (en) 2015-10-13 2016-10-12 Composition for treatment of inflammatory bowel disease and atopic dermatitis
JP2018519833A JP6885607B2 (en) 2015-10-13 2016-10-12 Compositions for the treatment of inflammatory bowel disease and atopic dermatitis
US15/768,374 US10278931B2 (en) 2015-10-13 2016-10-12 Composition for treatment of inflammatory bowel disease and atopic dermatitis
CN201680059836.6A CN108137490B (en) 2015-10-13 2016-10-12 Composition for treating inflammatory bowel disease and atopic dermatitis
HK18113385.6A HK1254242A1 (en) 2015-10-13 2018-10-18 Composition for treatment of inflammatory bowel disease and atopic dermatitis

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR10-2015-0142929 2015-10-13
KR20150142929 2015-10-13
KR1020160131313A KR101949451B1 (en) 2015-10-13 2016-10-11 A composition for treating inflammatory bowel disease and atopic dermatitis
KR10-2016-0131313 2016-10-11

Publications (2)

Publication Number Publication Date
WO2017065495A2 WO2017065495A2 (en) 2017-04-20
WO2017065495A3 true WO2017065495A3 (en) 2017-06-15

Family

ID=58517692

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2016/011434 WO2017065495A2 (en) 2015-10-13 2016-10-12 Composition for treatment of inflammatory bowel disease and atopic dermatitis

Country Status (1)

Country Link
WO (1) WO2017065495A2 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003037346A1 (en) * 2001-10-31 2003-05-08 Cell Therapeutics, Inc. 6-phenyl-n-phenyl-(1,3,5) -triazine-2,4-diamine derivatives and related compounds with lysophphosphatidic acid acyltransferase beta (lpaat-beta) inhibitory activity for use in the treatment of cancer
WO2004005509A1 (en) * 2002-07-02 2004-01-15 Genox Research, Inc. Method of examining allergic disaese and drug for treating the same
KR20110010763A (en) * 2008-05-09 2011-02-07 톨마 인코포레이티드 Proguanil to treat skin/mucosal diseases
US20130095140A1 (en) * 2011-01-07 2013-04-18 Elcelyx Therapeutics, Inc. Biguanide Compositions and Methods of Treating Metabolic Disorders

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003037346A1 (en) * 2001-10-31 2003-05-08 Cell Therapeutics, Inc. 6-phenyl-n-phenyl-(1,3,5) -triazine-2,4-diamine derivatives and related compounds with lysophphosphatidic acid acyltransferase beta (lpaat-beta) inhibitory activity for use in the treatment of cancer
WO2004005509A1 (en) * 2002-07-02 2004-01-15 Genox Research, Inc. Method of examining allergic disaese and drug for treating the same
KR20110010763A (en) * 2008-05-09 2011-02-07 톨마 인코포레이티드 Proguanil to treat skin/mucosal diseases
US20130095140A1 (en) * 2011-01-07 2013-04-18 Elcelyx Therapeutics, Inc. Biguanide Compositions and Methods of Treating Metabolic Disorders

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, 29 October 2002, Columbus, Ohio, US; abstract no. 467242-19-9 *
CHEMICAL ABSTRACTS, 30 October 2000, Columbus, Ohio, US; abstract no. 300382-90-5, XP055545202 *
See also references of EP3363783A4 *

Also Published As

Publication number Publication date
WO2017065495A2 (en) 2017-04-20

Similar Documents

Publication Publication Date Title
PL3668937T3 (en) Compositions and uses of z-1-chloro-2,3,3,3-tetrafluoroprop-1-ene
WO2015038796A3 (en) Secretion of heme-containing polypeptides
WO2017011820A3 (en) Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
EP3957711A3 (en) Detergent composition comprising amylase and protease variants
WO2015168643A3 (en) Compositions and methods related to engineered fc constructs
WO2015120062A3 (en) Therapeutic compounds and compositions
WO2015200902A8 (en) Endophytes, associated compositions, and methods of use thereof
WO2015132669A3 (en) Anti-foam compositions
WO2017015622A3 (en) Gdf11 binding proteins and uses thereof
EP3887342A4 (en) Yeast-based compositions for enhancing rhizosphere properties and plant health
SG10201908839QA (en) 2,4-dihydroxy-nicotinamides as apj agonists
WO2016044463A3 (en) Mk2 inhibitors and uses thereof
MX2016016143A (en) Substituted [1,2,4]triazole compounds.
EP3411504A4 (en) Anti-tnf antibodies, compositions, methods and use for the treatment or prevention of type 1 diabetes
IL251775A0 (en) Substituted 2, 4-diamino quinoline compounds, compositions comprising same and uses thereof
WO2015191945A3 (en) Solid state forms of sofosbuvir
WO2017136450A3 (en) Compounds and methods of treating rna-mediated diseases
WO2016106343A8 (en) Probiotic organisms for diagnosis, monitoring, and treatment of inflammatory bowel disease
PL3242957T3 (en) Bacteria-comprising compositions and methods of using the same for treating and/or preventing gastrointestinal, metabolic and/or other diseases
MX2017008390A (en) Alkoxysilane-functionalized and allophanate-functionalized urethanes.
EP3818085A4 (en) Compositions and uses thereof for treating disease or condition
WO2015186004A3 (en) Production of fc fragments
TWI799397B (en) Compositions for the treatment of hypertension
WO2016092561A3 (en) Novel polymorphs of ivacaftor, process for its preparation and pharmaceutical composition thereof
WO2016019036A3 (en) Recombinant collagen iv surrogates and uses thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16855712

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2018519833

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 15768374

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2016855712

Country of ref document: EP